论文部分内容阅读
目的:探究阿奇霉素治疗小儿支原体肺炎的临床效果。方法:选择我院2014年2月-2015年1月期间所收治的68例小儿支原体肺炎患者,依据入院就诊顺序单双号将其分为实验组与参照组,各34例。实验组患儿给予阿奇霉素治疗,参照组患儿给予红霉素治疗,比较两组患者的治疗效果与不良反应。结果:两组患儿的治疗愈显率比较无显著差异(P>0.05),症状消退时间、住院时间快于参照组(P<0.05),不良反应发生率低于参照组(P<0.05)。结论:应用阿奇霉素治疗小儿支原体肺炎效果显著,可使患儿迅速康复,且安全性较高,具有重要的临床实践意义。
Objective: To investigate the clinical effect of azithromycin in treating children with mycoplasma pneumonia. Methods: A total of 68 children with Mycoplasma pneumoniae pneumonia who were treated in our hospital from February 2014 to January 2015 were selected and divided into experimental group and reference group according to the sequence of single and double admission, 34 cases in each group. The experimental group was treated with azithromycin and the reference group was treated with erythromycin. The therapeutic effects and adverse reactions of the two groups were compared. Results: There was no significant difference between the two groups (P> 0.05), symptom regression time and hospitalization time were faster than the reference group (P <0.05), and the incidence of adverse reactions was lower than that of the reference group (P <0.05) . Conclusion: Azithromycin is effective in treating children with mycoplasmal pneumonia, which can make the children recover quickly and have high safety. It has important clinical practice significance.